{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:59:47Z","timestamp":1773871187052,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1007\/s00296-019-04324-6","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T16:54:05Z","timestamp":1557507245000},"page":"1229-1240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case\u2013control study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-3937","authenticated-orcid":false,"given":"Bradley J.","family":"Gardiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary C.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Snydman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"issue":"12","key":"4324_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","volume":"4","author":"MK Gandhi","year":"2004","unstructured":"Gandhi MK, Khanna R (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4(12):725\u2013738. https:\/\/doi.org\/10.1016\/S1473-3099(04)01202-2","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4324_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","volume":"235","author":"P Griffiths","year":"2015","unstructured":"Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235(2):288\u2013297. https:\/\/doi.org\/10.1002\/path.4437","journal-title":"J Pathol"},{"issue":"4","key":"4324_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A, Transplantation Society International CMVCG (2013) Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 96(4):333\u2013360. https:\/\/doi.org\/10.1097\/TP.0b013e31829df29d","journal-title":"Transplantation"},{"key":"4324_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-62703-788-4_2","volume":"1119","author":"MT Nogalski","year":"2014","unstructured":"Nogalski MT, Collins-McMillen D, Yurochko AD (2014) Overview of human cytomegalovirus pathogenesis. Methods Mol Biol 1119:15\u201328. https:\/\/doi.org\/10.1007\/978-1-62703-788-4_2","journal-title":"Methods Mol Biol"},{"issue":"11","key":"4324_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-013-2363-7","volume":"32","author":"T Ozaki","year":"2013","unstructured":"Ozaki T, Yamashita H, Kaneko S, Yorifuji H, Takahashi H, Ueda Y, Takahashi Y, Kaneko H, Kano T, Mimori A (2013) Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review. Clin Rheumatol 32(11):1683\u20131690. https:\/\/doi.org\/10.1007\/s10067-013-2363-7","journal-title":"Clin Rheumatol"},{"issue":"9","key":"4324_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","volume":"47","author":"Y Takizawa","year":"2008","unstructured":"Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47(9):1373\u20131378. https:\/\/doi.org\/10.1093\/rheumatology\/ken231","journal-title":"Rheumatology (Oxford)"},{"key":"4324_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-017-0456-3","author":"L Zhang","year":"2017","unstructured":"Zhang L, Tao J, Wen Y, Li L, Wu X, Li X, Li X (2017) Cytomegalovirus infection in patients with lupus nephritis: clinical and laboratory features and therapeutic considerations. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-017-0456-3","journal-title":"Clin Exp Med"},{"issue":"7","key":"4324_CR8","first-page":"1349","volume":"31","author":"T Mori","year":"2004","unstructured":"Mori T, Kameda H, Ogawa H, Iizuka A, Sekiguchi N, Takei H, Nagasawa H, Tokuhira M, Tanaka T, Saito Y, Amano K, Abe T, Takeuchi T (2004) Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol 31(7):1349\u20131351","journal-title":"J Rheumatol"},{"issue":"1","key":"4324_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP, Consortium BCC, British Society for Rheumatology Biologics R","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP, Consortium BCC, British Society for Rheumatology Biologics R (2011) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50(1):124\u2013131. https:\/\/doi.org\/10.1093\/rheumatology\/keq242","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4324_CR10","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00296-011-2131-4","volume":"32","author":"WP Tsai","year":"2012","unstructured":"Tsai WP, Chen MH, Lee MH, Yu KH, Wu MW, Liou LB (2012) Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int 32(9):2901\u20132908. https:\/\/doi.org\/10.1007\/s00296-011-2131-4","journal-title":"Rheumatol Int"},{"issue":"4","key":"4324_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0961203316671817","volume":"26","author":"N Berman","year":"2017","unstructured":"Berman N, Belmont HM (2017) Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem. Lupus 26(4):431\u2013434. https:\/\/doi.org\/10.1177\/0961203316671817","journal-title":"Lupus"},{"issue":"7","key":"4324_CR12","doi-asserted-by":"publisher","first-page":"e0181590","DOI":"10.1371\/journal.pone.0181590","volume":"12","author":"KY Lee","year":"2017","unstructured":"Lee KY, Yoo BW, Ahn SS, Bae WH, Lee H, Jung SM, Lee SW, Park YB, Song JJ (2017) Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR. PLoS ONE 12(7):e0181590. https:\/\/doi.org\/10.1371\/journal.pone.0181590","journal-title":"PLoS ONE"},{"issue":"1","key":"4324_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42358-019-0055-y","volume":"59","author":"HMC Choo","year":"2019","unstructured":"Choo HMC, Cher WQ, Kwan YH, Fong WWS (2019) Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol 59(1):12. https:\/\/doi.org\/10.1186\/s42358-019-0055-y","journal-title":"Adv Rheumatol"},{"issue":"6","key":"4324_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/MD.0b013e31818ec711","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, Bertolaccini L, Babini A, Moreno A, D'Cruz D, Khamashta MA (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87(6):311\u2013318. https:\/\/doi.org\/10.1097\/MD.0b013e31818ec711","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4324_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00124743-200208000-00011","volume":"8","author":"KH Yoon","year":"2002","unstructured":"Yoon KH, Fong KY, Tambyah PA (2002) Fatal cytomegalovirus infection in two patients with systemic lupus erythematosus undergoing intensive immunosuppressive therapy: role for cytomegalovirus vigilance and prophylaxis? J Clin Rheumatol 8(4):217\u2013222","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"4324_CR16","first-page":"559","volume":"20","author":"I Sekigawa","year":"2002","unstructured":"Sekigawa I, Nawata M, Seta N, Yamada M, Iida N, Hashimoto H (2002) Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20(4):559\u2013564","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"4324_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/RHU.0b013e3181f4cf52","volume":"16","author":"AE Perez-Mercado","year":"2010","unstructured":"Perez-Mercado AE, Vila-Perez S (2010) Cytomegalovirus as a trigger for systemic lupus erythematosus. J Clin Rheumatol 16(7):335\u2013337. https:\/\/doi.org\/10.1097\/RHU.0b013e3181f4cf52","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"4324_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/nep.13071","volume":"23","author":"CC Lim","year":"2017","unstructured":"Lim CC, Tung YT, Tan BH, Lee PH, Mok IY, Oon L, Chan KP, Choo JC (2017) Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology (Carlton) 23(7):676\u2013681. https:\/\/doi.org\/10.1111\/nep.13071","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"4324_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4081\/reumatismo.2016.897","volume":"68","author":"J Mencarini","year":"2016","unstructured":"Mencarini J, Spinicci M, Bartalesi F (2016) Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter? Reumatismo 68(3):144\u2013147. https:\/\/doi.org\/10.4081\/reumatismo.2016.897","journal-title":"Reumatismo"},{"issue":"3","key":"4324_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0366-6999.174490","volume":"129","author":"Y Xue","year":"2016","unstructured":"Xue Y, Jiang L, Wan WG, Chen YM, Zhang J, Zhang ZC (2016) Cytomegalovirus pneumonia in patients with rheumatic diseases after immunosuppressive therapy: a single center study in China. Chin Med J (Engl) 129(3):267\u2013273. https:\/\/doi.org\/10.4103\/0366-6999.174490","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"4324_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Kohler L, Van Riel P, Vischer T, Bijlsma JW (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718\u2013722","journal-title":"Ann Rheum Dis"},{"key":"4324_CR22","volume-title":"ICD-9-CM : International classification of diseases, 9th revision, clinical modification. Physician ICD-9-CM","author":"Ingenix Medicode","year":"1998","unstructured":"Medicode Ingenix (1998) ICD-9-CM : International classification of diseases, 9th revision, clinical modification. Physician ICD-9-CM, 5th edn. Medicode, Salt Lake City","edition":"5"},{"key":"4324_CR23","unstructured":"Genentech (2015) Valcyte (valganciclovir), package insert. Genentech, San Francisco, California, USA"},{"key":"4324_CR24","unstructured":"Genentech (2016) Cytovene (ganciclovir), package insert. Genentech, San Francisco, California, USA"},{"issue":"8","key":"4324_CR25","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00296-017-3693-6","volume":"37","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Nakajima S, Tanji K, Hirai T, Uomori K, Morimoto S, Tomita S, Fukunaga M, Tamura N, Sekigawa I (2017) Intestinal perforation due to hemorrhagic cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. Rheumatol Int 37(8):1395\u20131399. https:\/\/doi.org\/10.1007\/s00296-017-3693-6","journal-title":"Rheumatol Int"},{"issue":"6","key":"4324_CR26","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.3390\/v6062242","volume":"6","author":"PJ Hanley","year":"2014","unstructured":"Hanley PJ, Bollard CM (2014) Controlling cytomegalovirus: helping the immune system take the lead. Viruses 6(6):2242\u20132258. https:\/\/doi.org\/10.3390\/v6062242","journal-title":"Viruses"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-019-04324-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:40:12Z","timestamp":1659112812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-019-04324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"alternative-id":["4324"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04324-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DRS reports being on advisory boards for Merck, Shire, Chimerix, Takeda and Moderna and being a grant recipient from Merck, Summit, Actelion, Tetraphase and Seres Therapeutics. All other authors report no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Tufts Medical Center institutional review board (July 12, 2017, Approval Number 12618) and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was not required given its retrospective nature and minimal risk.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}